Skip to content

Author

Zi-Xian Liu

We have 2 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Schisandrin B attenuates the platelet activation-thrombosis cascade through inhibition of Phosphatidylinositol 3-kinase/AKT and Extracellular signal-regulated kinase-Talin-mediated integrin αIIbβ3 signaling.

ETHNOPHARMACOLOGICAL RELEVANCE Schisandrin B (Sch B), a principal bioactive lignan derived from Schisandra chinensis (Turcz.) Baill. exhibits diverse pharmacological activities. This traditional Chinese medicine possesses therapeutic value for treating symptoms such as palpitations, shortness of breath, and a faint, ne...

Meng-Yao Li, Zi-Xian Liu, Yue-Yue Shen et al. · 0 citations
Open access Aug 2026

POU2F1 promotes hypertensive cardiac fibrosis by regulating mitochondrial homeostasis through PINK1/Parkin-dependent mitophagy

A novel role is identified for POU2F1 in hypertensive cardiac fibrosis, demonstrating that it exacerbates disease progression by disrupting mitochondrial homeostasis through transcriptional activation of PINK1, accompanied by alterations consistent with enhanced PINK1/Parkin-mediated mitophagy signaling.

Yong-Bo Ma, Xiao-Zhe Chen, Zi-Xian Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.